# NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
> **ANDA211830** · Abbreviated New Drug Application (Generic) · Sponsor: COREPHARMA · Approved 2019-08-22
## Drug
- **FDA Application Number:** ANDA211830
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
- **Generic name:** Diphenhydramine Hydrochloride
- **Active ingredients:** DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** COREPHARMA
- **First approval:** 2019-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211830)
---
*MORVS · CC0 1.0*